Answers are grounded in this paper and cite their sources.
Creatinine is eliminated by the kidneys through a combination of glomerular filtration and active transport. Drug-induced increases in serum creatinine (SCr) and/or reduced creatinine renal clearance are used as a marker for acute kidney injury. However, inhibition of active transport of creatinine can result in reversible and, therefore, benign increases in SCr levels. Herein, the transporters involved in creatinine clearance are discussed, in addition to limitations of using creatinine as a biomarker for kidney damage.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: